Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population : Have we made progress? / Vourli, Georgia; Noori, Teymur; Pharris, Anastasia; Porter, Kholoud; Axelsson, Maria; Begovac, Josip; Cazein, Francoise; Costagliola, Dominique; Cowan, Susan; Croxford, Sara; Monforte, Antonella d.Arminio; Delpech, Valerie; Díaz, Asunción; Girardi, Enrico; Gunsenheimer-Bartmeyer, Barbara; Hernando, Victoria; Leierer, Gisela; Lot, Florence; Nunez, Olivier; Obel, Niels; Op de Coul, Eline; Paraskeva, Dimitra; Patrinos, Stavros; Reiss, Peter; Schmid, Daniela; Sonnerborg, Anders; Suligoi, Barbara; Supervie, Virginie; van Sighem, Ard; Zangerle, Robert; Touloumi, Giota; Egle, Alexander; Kanatschnig, Manfred; Öllinger, Angela; Rieger, Armin; Schmied, Brigitte; Wallner, Elmar; Dewasurendra, Diyani; Gisinger, Martin; Kitchen, Maria; Plattner, Alexander; Rieser, Elisabeth; Sarcletti, Mario; Greil, Richard; Schachner, Michaela; Skocic, Matthias; Müller, Monika; Kronborg, G.; Kvinesdal, B.; Honoré, P.; European HIV Continuum of Care Working Group.
I: Clinical Infectious Diseases, Bind 71, Nr. 11, 2020, s. 2905-2916.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population
T2 - Have we made progress?
AU - Vourli, Georgia
AU - Noori, Teymur
AU - Pharris, Anastasia
AU - Porter, Kholoud
AU - Axelsson, Maria
AU - Begovac, Josip
AU - Cazein, Francoise
AU - Costagliola, Dominique
AU - Cowan, Susan
AU - Croxford, Sara
AU - Monforte, Antonella d.Arminio
AU - Delpech, Valerie
AU - Díaz, Asunción
AU - Girardi, Enrico
AU - Gunsenheimer-Bartmeyer, Barbara
AU - Hernando, Victoria
AU - Leierer, Gisela
AU - Lot, Florence
AU - Nunez, Olivier
AU - Obel, Niels
AU - Op de Coul, Eline
AU - Paraskeva, Dimitra
AU - Patrinos, Stavros
AU - Reiss, Peter
AU - Schmid, Daniela
AU - Sonnerborg, Anders
AU - Suligoi, Barbara
AU - Supervie, Virginie
AU - van Sighem, Ard
AU - Zangerle, Robert
AU - Touloumi, Giota
AU - Egle, Alexander
AU - Kanatschnig, Manfred
AU - Öllinger, Angela
AU - Rieger, Armin
AU - Schmied, Brigitte
AU - Wallner, Elmar
AU - Dewasurendra, Diyani
AU - Gisinger, Martin
AU - Kitchen, Maria
AU - Plattner, Alexander
AU - Rieser, Elisabeth
AU - Sarcletti, Mario
AU - Greil, Richard
AU - Schachner, Michaela
AU - Skocic, Matthias
AU - Müller, Monika
AU - Kronborg, G.
AU - Kvinesdal, B.
AU - Honoré, P.
AU - European HIV Continuum of Care Working Group
PY - 2020
Y1 - 2020
N2 - Background. High uptake of antiretroviral treatment (ART) is essential to reduce human immunodeficiency virus (HIV) transmission and related mortality; however, gaps in care exist. We aimed to construct the continuum of HIV care (CoC) in 2016 in 11 European Union (EU) countries, overall and by key population and sex. To estimate progress toward the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 target, we compared 2016 to 2013 estimates for the same countries, representing 73% of the population in the region. Methods. A CoC with the following 4 stages was constructed: number of people living with HIV (PLHIV); proportion of PLHIV diagnosed; proportion of those diagnosed who ever initiated ART; and proportion of those ever treated who achieved viral suppression at their last visit. Results. We estimated that 87% of PLHIV were diagnosed; 92% of those diagnosed had ever initiated ART; and 91% of those ever on ART, or 73% of all PLHIV, were virally suppressed. Corresponding figures for men having sex with men were: 86%, 93%, 93%, 74%; for people who inject drugs: 94%, 88%, 85%, 70%; and for heterosexuals: 86%, 92%, 91%, 72%. The proportion suppressed of all PLHIV ranged from 59% to 86% across countries. Conclusions. The EU is close to the 90-90-90 target and achieved the UNAIDS target of 73% of all PLHIV virally suppressed, significant progress since 2013 when 60% of all PLHIV were virally suppressed. Strengthening of testing programs and treatment support, along with prevention interventions, are needed to achieve HIV epidemic control.
AB - Background. High uptake of antiretroviral treatment (ART) is essential to reduce human immunodeficiency virus (HIV) transmission and related mortality; however, gaps in care exist. We aimed to construct the continuum of HIV care (CoC) in 2016 in 11 European Union (EU) countries, overall and by key population and sex. To estimate progress toward the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 target, we compared 2016 to 2013 estimates for the same countries, representing 73% of the population in the region. Methods. A CoC with the following 4 stages was constructed: number of people living with HIV (PLHIV); proportion of PLHIV diagnosed; proportion of those diagnosed who ever initiated ART; and proportion of those ever treated who achieved viral suppression at their last visit. Results. We estimated that 87% of PLHIV were diagnosed; 92% of those diagnosed had ever initiated ART; and 91% of those ever on ART, or 73% of all PLHIV, were virally suppressed. Corresponding figures for men having sex with men were: 86%, 93%, 93%, 74%; for people who inject drugs: 94%, 88%, 85%, 70%; and for heterosexuals: 86%, 92%, 91%, 72%. The proportion suppressed of all PLHIV ranged from 59% to 86% across countries. Conclusions. The EU is close to the 90-90-90 target and achieved the UNAIDS target of 73% of all PLHIV virally suppressed, significant progress since 2013 when 60% of all PLHIV were virally suppressed. Strengthening of testing programs and treatment support, along with prevention interventions, are needed to achieve HIV epidemic control.
KW - Continuum of care
KW - Europe
KW - HIV infection
KW - Key population
KW - Sex
U2 - 10.1093/cid/ciaa696
DO - 10.1093/cid/ciaa696
M3 - Journal article
C2 - 32960957
AN - SCOPUS:85099326635
VL - 71
SP - 2905
EP - 2916
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
SN - 1058-4838
IS - 11
ER -
ID: 261511711